NOA‐03 trial of high‐dose methotrexate in primary central nervous system lymphoma: Final report
- 31 May 2005
- journal article
- clinical trial
- Published by Wiley in Annals of Neurology
- Vol. 57 (6) , 843-847
- https://doi.org/10.1002/ana.20495
Abstract
The NOA‐03 trial explored high‐dose methotrexate alone in 37 patients with primary central nervous system lymphoma. The overall median survival was 25 months. After 4 years, the rate of leukoencephalopathy in patients surviving more than 12 months was 58% with and 10% without whole‐brain radiotherapy given at relapse (p = 0.11). Attention deficits were found in all six tested patients, and memory deficits in four patients. Two patients had normal, three had moderately restricted, and one had markedly restricted quality of life. Thus, high‐dose methotrexate with deferred radiotherapy had only moderate efficacy and was associated with significant neurotoxicity in long‐term surviving patients. Ann Neurol 2005;57:843–847Keywords
This publication has 20 references indexed in Scilit:
- Cognitive status and quality of life after treatment for primary CNS lymphomaNeurology, 2004
- Cognitive functions in survivors of primary central nervous system lymphomaNeurology, 2004
- Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred RadiotherapyJournal of Clinical Oncology, 2003
- The Use of the Mini-Mental State Examination to Assess Cognitive Functioning in Cancer Trials: No Ifs, Ands, Buts, or SensitivityJournal of Clinical Oncology, 2003
- Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07Journal of Clinical Oncology, 2003
- Primary central nervous system lymphoma 1991-1997Cancer, 2001
- Effect of disease burden on health-related quality of life in patients with malignant gliomasNeuro-Oncology, 2000
- Effect of disease burden on health-related quality of life in patients with malignant gliomasNeuro-Oncology, 2000
- Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcomeJournal of Neurosurgery, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958